Nitric oxide: Relation to integrity, injury, and healing of the gastric mucosa

被引:87
作者
Calatayud, S [1 ]
Barrachina, D [1 ]
Esplugues, JV [1 ]
机构
[1] Univ Valencia, Fac Farm, Dept Farmacol, E-46010 Valencia, Spain
关键词
constitutive NO-synthase; endothelial NO-synthase; inducible NO-synthase; neuronal NO-synthase;
D O I
10.1002/jemt.1100
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Nitric oxide (NO) plays a multifaceted role in mucosal integrity. The numerous functions of NO and the double-edged role played by NO in most of them provide a great complexity to the NO action. The three enzymatic sources of NO, neuronal NO-synthase (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS), have been characterised in the gastrointestinal tract. The protective properties of the NO derived from constitutive NO-synthases (eNOS and nNOS) have already been well established. Less clear is the role assigned to iNOS. The simplistic initial view of low levels of NO synthesised by constitutive NOS being protective while exaggerated NO levels after iNOS induction leading irremediably to cytotoxicity is being questioned by new evidence. As initially reported for constitutive NOS, iNOS activity may be associated to reduced leukocyte-endothelium interaction and platelet aggregation as well as protection of mucosal microcirculation. Moreover, NOS activity may be important to resolve inflammation by increasing apoptosis in inflammatory cells. It is entirely possible that a low level of expression of iNOS will reflect a positive host-defense response to challenge, but that exaggerated or uncontrolled expression of iNOS itself becomes detrimental. There is no doubt about the protective role of NO in physiological conditions. However, when the mucosa is threatened, the role of NO becomes multiple and the final effect will probably depend on the nature of the insult, the environment involved, and the interaction with other mediators. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:325 / 335
页数:11
相关论文
共 129 条
[1]   Basic fibroblast growth factor increases constitutive nitric oxide synthase during healing of rat gastric ulcers [J].
Akiba, Y ;
Nakamura, M ;
Oda, M ;
Kimura, H ;
Miura, S ;
Tsuchiya, M ;
Ishii, H .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1997, 25 :S122-S128
[2]   A critical role for nitric oxide in intestinal barrier function and dysfunction [J].
Alican, I ;
Kubes, P .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1996, 270 (02) :G225-G237
[3]   PROTECTION AGAINST GASTRIC ISCHEMIA-REPERFUSION INJURY BY NITRIC-OXIDE GENERATORS [J].
ANDREWS, FJ ;
MALCONTENTIWILSON, C ;
OBRIEN, PE .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (02) :366-373
[4]   NITRIC-OXIDE DONORS PREFERENTIALLY INHIBIT NEURONALLY MEDIATED RAT GASTRIC-ACID SECRETION [J].
BARRACHINA, D ;
CALATAYUD, S ;
ESPLUGUES, J ;
WHITTLE, BJR ;
MONCADA, S ;
ESPLUGUES, JV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 262 (1-2) :181-183
[5]   NITRIC-OXIDE AND SENSORY AFFERENT NEURONS MODULATE THE PROTECTIVE EFFECTS OF LOW-DOSE ENDOTOXIN ON RAT GASTRIC-MUCOSAL DAMAGE [J].
BARRACHINA, MD ;
CALATAYUD, S ;
MORENO, L ;
MARTINEZCUESTA, MA ;
WHITTLE, BJR ;
ESPLUGUES, JV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 280 (03) :339-342
[6]   ENDOTOXIN INHIBITION OF DISTENSION-STIMULATED GASTRIC-ACID SECRETION IN RAT - MEDIATION BY NO IN THE CENTRAL-NERVOUS-SYSTEM [J].
BARRACHINA, MD ;
WHITTLE, BJR ;
MONCADA, S ;
ESPLUGUES, JV .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (01) :8-12
[7]   TRANSDERMAL NITROGLYCERIN PREVENTS NONSTEROIDAL ANTIINFLAMMATORY DRUG GASTROPATHY [J].
BARRACHINA, MD ;
CALATAYUD, S ;
CANET, A ;
BELLO, R ;
DEROJAS, FD ;
GUTH, PH ;
ESPLUGUES, JV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (02) :R3-R4
[8]   ENDOGENOUSLY FORMED N-NITROSO COMPOUNDS AND NITROSATING AGENTS IN HUMAN CANCER ETIOLOGY [J].
BARTSCH, H ;
OHSHIMA, H ;
PIGNATELLI, B ;
CALMELS, S .
PHARMACOGENETICS, 1992, 2 (06) :272-277
[9]   Synthesis of nitric oxide in the dorsal motor nucleus of the vagus mediates the inhibition of gastric acid secretion by central bombesin [J].
Beltrán, B ;
Barrachina, MD ;
Méndez, A ;
Quintero, E ;
Esplugues, JV .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (07) :1603-1610
[10]  
Bilski J, 1994, J Physiol Pharmacol, V45, P541